Savran Technologies is developing non-invasive diagnostics based on capture and analysis of rare cells. Savran Technologies has developed and completed initial testing of a novel liquid biopsy technology. Savran Tech has overcome the challenge of utilizing cell-based liquid biopsy. Cells offer significant advantages over cell-free DNA in diagnostics — for example, they provide access to the entire genome; can provide transcriptional and functional information; can differentiate between primary tumor and metastases; can be cultured for drug screening; and can offer insights into tumor heterogeneity.

We provide shared lab and office space for life science and biotech startups. Learn more about us here.

Contact Us 

(617) 245-8548

frontdesk@nest.bio

325 Vassar St. 

Cambridge, MA 02139

Our Services

Quick Links

  • LinkedIn
  • Facebook
  • Twitter
  • Instagram